Expression of glucokinase in skeletal muscle: A new approach to counteract diabetic hyperglycemia

Human Gene Therapy

Volumn 11, Issue 11, 2000, Pages 1543-1552

  Otaegui, P J ^a   Ferre, T ^a   Pujol, A ^a   Riu, E ^a   Jimenez, R ^a   Bosch, F ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENE THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; MOUSE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLUCOKINASE; HYPERGLYCEMIA; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; RATS; STREPTOZOCIN;

ANIMALIA; MUS MUSCULUS;

EID: 0034691510     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050083270     Document Type: Article

References (50)

1. Determination of adenosine-5'-diphosphate and adenosine-5'-monophosphate
2. Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage
3. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes
4. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM
5. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats
6. Overexpression of hexokinase II in transgenic mice
7. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases
8. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetic genes
9. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
10. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
11. Rostrocaudal gradient of transgene expression in adult skeletal muscle
12. Hexokinase type II from rat skeletal muscle
13. A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anesthetized rat
14. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver
15. Correction of diabetic alterations by glucokinase
16. Evidence that glucose transport is rate-limiting for in vivo glucose uptake
17. Role of glucose transporters in the insulin resistance of type II non-insulin-dependent diabetes mellitus
18. Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight
19. Expression of an insulin-responsive glucose transporter (GLUT4) minigene in transgenic mice: Effect of exercise and role in glucose homeostasis
20. Mammalian glucokinase and its gene
21. Heterogenous expression of glucokinase among pancreatic β-cells
22. Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes
23. Glucose transport: Pivotal step in insulin action
24. Glycogen
25. ATP determination with hexokinase and glucose-6-phosphate dehidrogenase
26. Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control
27. Phenotype of transgenic mice overexpressing GLUT4 and hexokinase II in muscle
28. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle
29. Glucokinase as glucose sensor and metabolic signal regenerator in pancreatic beta-cells and hepatocytes
30. Glucose 6-phosphate
31. Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats
32. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism
33. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family
34. Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice
35. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM
36. Development and regulation of glucose transporter and hexokinase expression in rat
37. Hexokinase II mRNA and gene structure, regulation by insulin, and evolution
38. Mammalian glucokinase
39. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice
40. Myosin light chain enhacer activates muscle-specific, developmentally regulated gene expression in transgenic mice
41. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate
42. Determination of blood sugar
43. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene
44. Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization
45. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients
46. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients